If you experience any side effects, the study team will closely monitor your condition and provide appropriate medical care. You will be informed of potential side effects before the study begins.
Take Back Control of Your Gut
About Clostridium difficile infection (CDI)
Clostridium difficile infection (CDI) is a serious bacterial infection affecting the colon, often leading to severe diarrhea and intestinal inflammation. Highly contagious and challenging to manage, CDI significantly impacts patient health and healthcare systems. In the United States alone, CDI accounts for approximately 223,900 cases annually.
While recurrent infections are a major concern, innovative treatments are offering hope for better management. Hightower Clinical Research has been at the forefront, exploring the safety and efficacy of investigational drugs administered via colonoscopy to adults suffering from recurrent CDI.
Current Status
Not Recruiting
Study Count
01
Study Information
Clostridium Difficile
| Study Name | Protocol Number | Sponsor |
|---|---|---|
| Clostridium Difficile | 000416 | Ferring |
Frequently Asked Questions
Do I need to stop taking my current medications to participate?
Some medications may be restricted during the study to ensure accurate results. The study team will provide guidance on which medications can be continued or need to be temporarily paused.
What is the investigational treatment, and how is it administered?
The investigational treatment involves the administration of a drug via colonoscopy for recurrent Clostridium difficile infection. The study team will explain the procedure and answer any questions before treatment begins.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.